| 000 | 01657 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516235814.0 | ||
| 264 | 0 | _c20150903 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1473-5849 | ||
| 024 | 7 |
_a10.1097/FBP.0000000000000096 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuot, Philippe | |
| 245 | 0 | 0 |
_aL-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned rat. _h[electronic resource] |
| 260 |
_bBehavioural pharmacology _cFeb 2015 |
||
| 300 |
_a101-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSpecies Specificity |
| 700 | 1 | _aJohnston, Tom H | |
| 700 | 1 | _aKoprich, James B | |
| 700 | 1 | _aEspinosa, Maria C | |
| 700 | 1 | _aReyes, Maria Gabriela | |
| 700 | 1 | _aFox, Susan H | |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 773 | 0 |
_tBehavioural pharmacology _gvol. 26 _gno. 1-2 _gp. 101-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FBP.0000000000000096 _zAvailable from publisher's website |
| 999 |
_c24267702 _d24267702 |
||